Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 017806
Company: LANTHEUS MEDCL
Company: LANTHEUS MEDCL
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
THALLOUS CHLORIDE TL 201 | THALLOUS CHLORIDE TL-201 | 1mCi/ML | INJECTABLE;INJECTION | Prescription | AP | Yes | Yes |
THALLOUS CHLORIDE TL 201 | THALLOUS CHLORIDE TL-201 | 2mCi/ML | INJECTABLE;INTRAVENOUS | Discontinued | None | Yes | No |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
08/25/2011 | SUPPL-25 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017806s025lbl.pdf |